Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 20;66(9):e0059522.
doi: 10.1128/aac.00595-22. Epub 2022 Aug 30.

Molecular and Kinetic Characterization of MOX-9, a Plasmid-Mediated Enzyme Representative of a Novel Sublineage of MOX-Type Class C β-Lactamases

Affiliations

Molecular and Kinetic Characterization of MOX-9, a Plasmid-Mediated Enzyme Representative of a Novel Sublineage of MOX-Type Class C β-Lactamases

Alessandra Piccirilli et al. Antimicrob Agents Chemother. .

Abstract

The MOX lineage of β-lactamases includes a group of molecular class C enzymes (AmpCs) encoded by genes mobilized from the chromosomes of Aeromonas spp. to plasmids. MOX-9, previously identified as a plasmid-encoded enzyme from a Citrobacter freundii isolate, belongs to a novel sublineage of MOX enzymes, derived from the resident Aeromonas media AmpC. The blaMOX-9 gene was found to be carried on a transposon, named Tn7469, likely responsible for its mobilization to plasmidic context. MOX-9 was overexpressed in Escherichia coli, purified, and subjected to biochemical characterization. Kinetic analysis showed a relatively narrow-spectrum profile with strong preference for cephalosporin substrates, with some differences compared with MOX-1 and MOX-2. MOX-9 was not inhibited by clavulanate and sulbactam, while both tazobactam and avibactam acted as inhibitors in the micromolar range.

Keywords: MOX; enzyme kineticss; β-lactamases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIG 1
FIG 1
Phylogenetic tree showing the relationship of enzymes of the MOX lineage (of which some are named CMY). Sequences have been aligned with the MAFFT webserver (https://mafft.cbrc.jp/alignment/server/) and the tree has been built by using the neighbor-joining method and 1,000 bootstraps. The tree was rooted on the CMY-2 sequence used as an outgroup. Sequences were retrieved from the NCBI reference gene catalog (https://www.ncbi.nlm.nih.gov/pathogens/refgene).
FIG 2
FIG 2
Genetic context of the blaMOX-9 gene in C. freundii Cfr-FI-07 and its comparison to segments of the A. media R1-26 genome (region 3,313,893.3,318,039; accession number CP043579) and to the A. caviae pKAM376_5 plasmid. The Tn7469 transposon is indicated with a brace and its target site duplications are shown with yellow diamonds flanking the transposon. The ISKpn9-like element involved in the mobilization of blaMOX-9 is boxed. Regions showing ≥99% nucleotide sequence identity are connected by blue areas. Hypothetical proteins are depicted in gray, while the IS5 element disrupted by Tn7469 transposition is in red.

References

    1. Jacoby GA. 2009. AmpC β-lactamases. Clin Microbiol Rev 22:161–182. 10.1128/CMR.00036-08. - DOI - PMC - PubMed
    1. Meini S, Tascini C, Cei M, Sozio E, Rossolini GM. 2019. AmpC β-lactamases-producing Enterobacterales: what a clinician should know. Infection 47:363–375. 10.1007/s15010-019-01291-9. - DOI - PubMed
    1. Perilli M, Felici A, Oratore A, Cornaglia G, Bonfiglio G, Rossolini GM, Amicosante G. 1996. Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother 40:715–719. 10.1128/AAC.40.3.715. - DOI - PMC - PubMed
    1. Tavio MM, Perilli M, Vila J, Becerro P, Casanas L, Amicosante G, Jimenez de Anta MT. 2004. Salicylate decreases production of AmpC type β-lactamases and increases susceptibility to β-lactams in a Morganella morganii clinical isolate. FEMS Microbiol Lett 238:139–144. 10.1016/j.femsle.2004.07.030. - DOI - PubMed
    1. Oguri T, Furuyama T, Okuno T, Ishii Y, Tateda K, Bonomo RA, Shimizu-Ibuka A. 2014. Crystal structure of MOX-1, a unique plasmid-mediated class C β-lactamase with hydrolytic activity towards moxalactam. Antimicrob Agents Chemother 58:3914–3920. 10.1128/AAC.02363-13. - DOI - PMC - PubMed

Publication types

LinkOut - more resources